Abstract
Background:
Active immunization is the most important measure for controlling hepatitis B (HB) virus infection. The outcome of HB vaccination has been investigated in only a very small number of cohort studies, some of which found a number of cases of HBV infection.
Material and Methods:
Using a design different from that of earlier studies, we have investigated the occurrence of HBV infection and clinical HB disease in individuals who had a complete HB vaccination series. Reported cases of HB/HBV infections among 1235 German health care workers (HCW) were analyzed with special regard to the question of whether or not HB vaccination had taken place in the past.
Results:
23 persons had undergone a complete vaccination series with complete documentation: 18 were non-responders (post-vaccination anti-HBs < 10 IU/l), one was a low-responder (anti-HBs < 100 IU/l), and four were responders (100 IU/l).While all responders seroconvertedwithout clinical sign of hepatitis, ten non-/low-responders contracted chronic HB/HBV infection and seven contracted self-limiting HB.
Conclusion:
Vaccination should be only regarded as “successful”, if the post-vaccination anti-HBs concentration is at least 100 IU/l.
References
Goudeau A, Coursaget P, Barin F, Dubois F, Chiron JP, Denis F, Diop-Mar J: Prevention of hepatitis B by active and passiveactive immunization. In: Szmuness W, Alter HJ, Maynard JE (eds): Viral Hepatitis, 1981 International Symposium. The Franklin Institute Press, Philadelphia 1982, pp 509–525.
Robert Koch-Institut, Berlin: Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut — Stand: July 2005 (Recommendations of the Permanent Commission for Vaccinations on Robert Koch-Institute, in German). Epidemiol Bull 2005; 30: 257–274.
Couroucé AM, Laplanche A, Benhamou E, Jungers P: Long-term efficacy of hepatitis B vaccination in healthy adults. In: Zuckerman AJ (eds): Viral Hepatitis and Liver Disease. Alan R Liss Inc, New York 1988, pp 1002–1005.
Gibas A, Watkins E, Hinkle C, Dienstag JL: Long-term persistence of protective antibody after hepatitis B vaccination of healthy adults. In: Zuckerman AJ (eds): Viral Hepatitis and Liver Disease. Alan R Liss Inc, New York 1988, pp 998–1001.
Bell DM, Shapiro CN, Ciesielski CA, Chamberland ME: Preventing bloodborne pathogen transmission from health-care workers to patients — The CDC perspective. Surg Clin North Am 1995; 75: 1189–1203.
Hadler SC, Francis DP, Maynard JE, Thompson SE, Judson FN, Echenberg DF, Ostrow DG, O’Malley PM, Penley KA, Altman NL: Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N Engl J Med 1986; 315: 209–214.
Hadler SC, Coleman PJ, O’Malley P, Judson FN, Altman N: Evaluation of long-term protection by hepatitis B vaccine for seven to nine years in homosexual men. In: Hollinger FB, Lemon SM, Margolis H (eds): Viral hepatitis, liver disease. Williams and Wilkins, Baltimore 1991, pp 766–768.
Stevens CE, Taylor PE, Tong MJ, Toy PT, Vyas GN: Hepatitis-Bvaccine: An overview. In: Yvas GN, Dienstag JL, Hoofnagle JH (eds): Viral hepatitis and liver disease. Grune and Stratton, Orlando 1984, pp 275–291.
Wainwright RB, McMahon BL, Bulkow LR, Parkinson AJ, Harpster AP, Hadler SC: Duration of immunogenicity and efficacy of hepatitis B vaccine in a Yupik Eskimo population — preliminary results of an 8-year study. In: Hollinger FB, Lemon SM, Margolis H (eds): Viral hepatitis and liver disease. Williams and Wilkins, Philadelphia 1991, pp 762–766.
Schenkel K, Radun D, Bocter N, Hamouda O: Viral hepatitis in Germany: poor vaccination coverage and little knowledge about transmission in target groups. BMC Public Health 2008; 8: 132–143.
Hofmann F, Hambraeus L, Hagberg M, Böttiger M: Berufsbedingte Infektionskrankheiten beim Personal des schwedischen und des bundesdeutschen Gesundheitsdienstes (occupationally acquired infectious diseases in Swedish and German Health Care Workers — in German). In: Hofmann F, Stössel U (eds): Arbeitsmedizin im Gesundheitsdienst 5 (occupational health in health care workers 5). Gentner Verlag, Stuttgart 1991, pp 127–131.
Tanner J, Parkinson H: Double gloving to reduce surgical crossinfection (Cochrane Review) In: The Cochrane Library, Issue 3, Oxford, Update Software 2003.
Dale J, Pruett S, Maker M: Accidental needlesticks in the phlebotomy service of the Department of Laboratory Medicine and Pathology at Mayo Clinic Rochester. Mayo Clin Proc 1998; 73: 611–615.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hofmann, F., Kralj, N. Criteria for Successful Hepatitis B Vaccination in Adults: Results of a Case Study. Infection 37, 266–269 (2009). https://doi.org/10.1007/s15010-008-7410-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15010-008-7410-y